p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2
Oral squamous cell carcinoma (OSCC), a form of head and neck squamous cell carcinoma (HNSCC) has a poor 5-year survival rate. OSCC patients are often treated with cisplatin but resistance to chemotherapy is of...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Xiao-han Li, Dan Li, Chang Liu, Ming-ming Zhang, Xiao-jiao Guan and Ya-ping Fu Tags: Primary research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Head and Neck Cancer | HNSCC | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma